Top Markets
Coin of the day
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
Rangering i aksjer #39891
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Aksjekurs
$0.80961743
Sist synkronisert: 2026-08-13
Markedsverdi
$305.68K
Endring (1 dag)
0.00%
Endring (1 år)
-5.76%
Land
GB
Handel Arecor Therapeutics plc (AREC)

Kategori

Antall utestående aksjer for Arecor Therapeutics plc (AREC)
Antall utestående aksjer per August 2026: 0
Ifølge Arecor Therapeutics plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Arecor Therapeutics plc (AREC) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE